Pharmacokinetics study of BHV-4157

Trial Profile

Pharmacokinetics study of BHV-4157

Phase of Trial: Phase I

Latest Information Update: 20 Jul 2016

At a glance

  • Drugs Trigriluzole (Primary)
  • Indications Mental disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Jul 2016 According to Biohaven media release, company has begun dosing subjects in this trial to evaluate the safety and pharmacokinectics of BHV-4157 after receiving the FDA clearance on its IND.
    • 20 Jul 2016 Status changed from not yet recruiting to recruiting, as per Biohaven media release.
    • 07 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top